In somatotropinomas, E-cadherin expression correlates positively with GH and IGF-1 secretion and and with somatostatin analogue treatment, and negatively with tumor size and invasiveness [82]. The gene discussed is IGF1; the disease is growth hormone-producing pituitary gland neoplasm.